Leukaemia UK
LightNews LightNews
banner
leukaemiauk.bsky.social
Leukaemia UK
@leukaemiauk.bsky.social
180 followers 130 following 160 posts
We fund groundbreaking research to stop leukaemia devastating lives by accelerating progress in diagnosis, treatment and care. 🧡
Posts Replies Media Videos
leukaemiauk.bsky.social
What does the Government’s new National Cancer Plan mean for people with leukaemia?

In our latest blog, we take an in-depth look at the commitments that could transform diagnosis, treatment and care for leukaemia patients. 👇
www.leukaemiauk.org.uk/news/nationa...
The National Cancer Plan: what does it mean for people with leukaemia? - Leukaemia UK
The Government’s new National Cancer Plan for England, which launched on World Cancer Day 2026, marks the most significant progress in policy for leukaemia and other blood cancers in more...
www.leukaemiauk.org.uk
February 11, 2026 at 1:58 PM
leukaemiauk.bsky.social
📢 A huge win for #WorldCancerDay!

The Government has announced a new metric to track early diagnosis for leukaemia, as part of the National Cancer Plan.

We’ve campaigned for this commitment & will work to ensure it delivers for leukaemia patients. 🧡
Today’s National Cancer Plan marks a major breakthrough in improving early diagnosis for leukaemia, with a new metric aiming to reduce the number of cancers diagnosed in an emergency setting – something we have campaigned for relentlessly. This is a major step forward for people with leukaemia and a huge testament to the strength of our community’s voices. We are now ready to work with Government to ensure this plan will deliver earlier diagnosis, improved survival and better quality of life for the thousands of people diagnosed with leukaemia every year. Together, we will stop leukaemia devastating lives. Fiona Hazell, Leukaemia UK CEO
February 4, 2026 at 12:47 PM
leukaemiauk.bsky.social
With the National Cancer Plan set to be published tomorrow, our CEO Fiona Hazell sets out why the Government must urgently commit to earlier diagnosis targets for leukaemia - to improve outcomes and to save lives
healthcaretoday.com/article/comm...
healthcaretoday.com
February 3, 2026 at 2:56 PM
leukaemiauk.bsky.social
This week, the Government will launch its National Cancer Plan for England.
We’re keeping you updated with the latest developments - including a £200m investment in local cancer care and greater access to trials for rare cancer patients - and our response. www.leukaemiauk.org.uk/news/latest-...
The latest developments and our response - Leukaemia UK
The government is set to launch the National Cancer Plan for England on 4th February. We are urging policymakers to ensure it delivers meaningful change specifically for people with leukaemia....
www.leukaemiauk.org.uk
February 2, 2026 at 4:04 PM
leukaemiauk.bsky.social
Could blocking a specific signalling pathway weaken AML cells and pave the way for new targeted treatments?

Researchers have developed a drug designed to block key proteins found in Interleukin-1 (IL-1) - a signalling pathway relied upon by AML cells.

🔗 medicine.iu.edu/news/2026/01...
Red blood cells in the bloodstream. The text on top of the image reads, ‘Researchers develop new drug which could lead to more effective, targeted treatments for AML’ with the Leukaemia UK logo.
January 27, 2026 at 11:29 AM
leukaemiauk.bsky.social
It was great to see the Rare Cancers Bill pass its Second Reading in the House of Lords last week. Thank you to Baroness Delyth Morgan for speaking about the poor survival rates for AML and raising the issues in leukaemia that the bill hopes to address. 🤞
January 20, 2026 at 11:25 AM
leukaemiauk.bsky.social
Congrats to Dr Matthew Blunt & team on their latest publication, revealing findings which could help to treat autoimmune disease. 👏

A great example of how discoveries in blood cancer research can drive progress across other areas of medicine! ✨

academic.oup.com/cei/advance-...
Dr Matthew Blunt, one of Leukaemia UK’s John Goldman Fellows and follow-up fund recipients. The text reads, ‘New paper: Leukaemia research reveals findings which could help to treat autoimmune diseases’ with the Leukaemia UK logo.
January 15, 2026 at 12:53 PM
leukaemiauk.bsky.social
We’re thrilled to hear that patients are already receiving Aucatzyl, a novel CAR-T therapy for B-ALL, less than a month after it was approved for use on the NHS.

We’re proud to have advocated for its approval with @anthonynolan.bsky.social @leukaemiacare.bsky.social 🧡
www.bbc.co.uk/news/article...
First leukaemia patient to get pioneering drug on NHS says it is 'very sci-fi'
Oscar Murphy has an aggressive form of the blood cancer and is the first to get CAR-T therapy in the UK.
www.bbc.co.uk
January 14, 2026 at 11:49 AM
leukaemiauk.bsky.social
Just incredible! Did you know that umbilical cord blood is rich in stem cells, and can be used for stem cell transplants - a crucial treatment option for many leukaemia patients? 🩸
www.bbc.co.uk/news/article...
Mum hails cord blood donation after life-saving transplant
Natasha Kirkpatrick had herself donated after giving birth - five years before her daughter's transplant.
www.bbc.co.uk
January 12, 2026 at 11:15 AM
leukaemiauk.bsky.social
A fascinating study by our co-funded researcher, Dr Katrin Ottersbach @edinburgh-uni.bsky.social, brings us closer to understanding why infant leukaemia is so hard to treat - and how future therapies might better target the disease.

🔗 www.exphem.org/article/S030...
An image of red blood cells in the bloodstream. The text reads, ‘New study brings us a step closer to understanding infant leukaemia - and why it is so difficult to treat’.
January 9, 2026 at 2:03 PM
leukaemiauk.bsky.social
A fantastic start to the year! Venetoclax with obinutuzumab has been approved on the NHS in England for people with untreated CLL, expanding access to a fixed-duration, targeted first-line treatment option. 👏
An orange graphic which reads, ‘New treatment for chronic lymphocytic leukaemia in England: Venetoclax with obinutuzumab’ followed by ‘Approved’ with a green tick symbol.
January 8, 2026 at 11:32 AM
leukaemiauk.bsky.social
Are you enthusiastic about research and its potential to improve our understanding of leukaemia, develop kinder treatments and enhance patient care?

Apply to be our next Research Manager 👉 www.leukaemiauk.org.uk/about-us/wor...
Three people are sat around a table in an office. They are pointing to a piece of paper and smiling. In the background, on the wall, the writing reads, ‘Discoveries happen all the time’. The text on the image reads, ‘We’re hiring! Research Manager'.
January 7, 2026 at 1:58 PM
leukaemiauk.bsky.social
📢 Gentler, smarter and more personalised therapies are reshaping the future of leukaemia treatment and care.

We took a deep dive into some of the key takeaways from this year’s American Society of Haematology (ASH) conference. 🩸 #ASH25 @ash.hematology.org

www.leukaemiauk.org.uk/stories/rese...
A conference hall with signs and exhibition stands. The entrance sign reads, ‘American Society of Hematology’.
December 18, 2025 at 5:19 PM
leukaemiauk.bsky.social
Last week, we shared the fantastic news about BE-CAR7 - a world-first therapy using CRISPR technology to treat T-cell leukaemia. 🔬

But what exactly is CRISPR? How is it different from standard CAR-T therapy? And why is it such a big deal? 👇

www.leukaemiauk.org.uk/stories/rese...
Research blog: The rise of CRISPR - Leukaemia UK
Last June, we introduced the concept of CRISPR in the context of CAR-T therapy and the rapid progress in immunotherapy. Today, CRISPR is moving from theory to practice, emerging as...
www.leukaemiauk.org.uk
December 17, 2025 at 12:00 PM
leukaemiauk.bsky.social
It was a pleasure to attend @ash.hematology.org this week and learn about all of the promising advancements in leukaemia treatment and care - from gentler treatments for AML to next-gen CAR-T therapies.

Look out for our upcoming blog for a deeper dive! #ASH25 🩸
Dr Simon Ridley, Director of Research & Advocacy at Leukaemia UK, at the American Society of Hematology (ASH) conference in Orlando. He is standing in front of a red backdrop with the ASH logo. Multiple screens showing the American Society of Hematology (ASH) logo on a red backdrop. A person is sitting behind a table on stage and there are silhouettes of several people with cameras.
December 12, 2025 at 12:34 PM
leukaemiauk.bsky.social
A major breakthrough! A world-first therapy - BE-CAR7 - is using base-edited immune cells to treat T-cell acute lymphoblastic leukaemia (T-ALL) - one of the most aggressive and hardest-to-treat types of leukaemia.
https://www.bbc.co.uk/news/articles/cj38ymeyg4mo
Blood cancer therapy reverses incurable leukaemia in some patients
Seven out of 11 patients with incurable cancer who had the treatment appear to be cancer-free.
www.bbc.co.uk
December 9, 2025 at 11:12 AM
leukaemiauk.bsky.social
We are delighted to announce further funding into ground-breaking research in 2026, by continuing our investment in early career scientists & clinicians!

📢 Applications for our 2026 John Goldman Fellowships are now open.

Find out more: www.leukaemiauk.org.uk/research-and...
Two images of Leukaemia UK’s John Goldman Fellows for 2023 and 2024. The text reads, ‘Apply for our 2026 John Goldman Fellowships’.
December 3, 2025 at 4:35 PM
leukaemiauk.bsky.social
📢 A significant step forward in expanding treatment options for B-ALL.

We’re thrilled that Aucatzyl - a CAR-T cell therapy for treating relapsed or refractory B-cell acute lymphoblastic leukaemia - has been approved for use on the NHS in England.

www.leukaemiauk.org.uk/news/leukaem...
An orange graphic which reads, ‘New drug for B-cell acute lymphoblastic leukaemia in England: Aucatzyl' followed by ‘Approved’ with a green tick symbol.
November 25, 2025 at 10:38 AM
leukaemiauk.bsky.social
How incredible is this?! Huge congratulations and a big thank you to Shaun and Salim, who completed the world’s most dangerous dive to raise funds for life-changing leukaemia research in memory of their friend, Trish. 🧡👏
www.express.co.uk/news/uk/2135...
Incredible disabled UK adventurers both survive the 'Diver's Cemetery'
EXCLUSIVE: The two friends took on the world's most dangerous dive site, in Egypt, which requires skill and stamina to survive.
www.express.co.uk
November 24, 2025 at 5:08 PM
leukaemiauk.bsky.social
The recipient of our 2025 Patient Care Pioneer Award: Dr Sarah Stapleton 🏆

Dr Stapleton will look at the psychological support that leukaemia patients might need, and develop a framework to help guide healthcare professionals.

www.leukaemiauk.org.uk/research-and...
November 17, 2025 at 2:58 PM
leukaemiauk.bsky.social
Major breakthrough for T-ALL! Researchers have identified a previously unknown subtype, which can be detected using routine tests. 👏

This means clinicians could soon pinpoint high-risk cases at diagnosis & personalise treatment for children with T-ALL.

bioengineer.org/breakthrough...
An image of a T-cell, a type of lymphocyte which plays a vital role in the body’s immune system. The text on the image reads, ‘Major study uncovers new subtype of T-cell ALL, which can be detected using routine tests at point of diagnosis’.
November 13, 2025 at 5:51 PM
leukaemiauk.bsky.social
This is deeply concerning. Early diagnosis is crucial for successful treatment in all cancers, including leukaemia, which is why we’re calling on the Government to commit to urgently tackling delays in early diagnosis in their upcoming National Cancer Plan.
www.bbc.co.uk/news/article...
Nearly all NHS hospitals are missing cancer targets - is yours one of them?
Experts say patients are being harmed by cancer diagnosis and treatment delays.
www.bbc.co.uk
November 13, 2025 at 10:51 AM
leukaemiauk.bsky.social
Last chance to share your views! How do you want to hear about the impact of your incredible support?

We want to make sure that you’re the first to know about the life-saving research we’re funding, all thanks to you. 🧡

Have your say: https://survey.alchemer.eu/s3/90953656/a60c0b257002
A scientist working in a lab. He is wearing a white lab coat and using a microscope and test tubes. The text on the image reads, ‘Have your say’ alongside an icon of a person holding a tablet and filling out an online survey.
November 6, 2025 at 11:30 AM
leukaemiauk.bsky.social
Promising news! Researchers have found that statins, a cholesterol-lowering drug, could help to tackle “chemo brain” - a debilitating cognitive side effect for many cancer patients. 🤞

www.independent.co.uk/news/health/...
The common drug that can reduce side effects for cancer patients
The common cholesterol-lowering medication protects patients’ mental skills used to plan, organise and manage emotions
www.independent.co.uk
November 5, 2025 at 1:21 PM
leukaemiauk.bsky.social
We want to hear from you - our fantastic supporters!

How can we keep you informed about the impact of your incredible support, and how it’s helping us to fund life-changing leukaemia research?

Fill in our short survey by midnight on Mon 10th Nov: survey.alchemer.eu/s3/90953656/...
A graphic with an icon of a person holding a tablet in their hands and filling out an online survey. The text reads, ‘Share your views. How do you want to hear about the impact of your support?’
October 31, 2025 at 12:05 PM